✦ LIBER ✦

Dose-independent synergistic response with gemcitabine and cisplatin in anthracycline-resistant breast cancer and reversal of resistance to gemcitabine with addition of paclitaxel

✍ Scribed by Renuka Gupta; Harinder Sawhney; Sudar Cynthia; Pradeep Chandra

Book ID: 118627871
Publisher: Frontline Medical Communications, Inc.
Year: 2007
Tongue: English
Weight: 85 KB
Volume: 4
Category: Article
ISSN: 1548-5315
DOI: 10.1016/s1548-5315(11)70145-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of low-dose combined therapy with ge

Use of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysis

✍ Yasuyoshi Miyata, Koichiro Nomata, Kojiro Ohba… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 226 KB

High efficacy of gemcitabine and cisplat

High efficacy of gemcitabine and cisplatin in patients with predominantly anthracycline- and taxane-pretreated metastatic breast cancer

✍ V. Heinemann; H. J. Stemmler; A. Wohlrab; D. Bosse; C. Losem; S. Kahlert; G. Rau 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 235 KB

A phase II study of gemcitabine plus pac

A phase II study of gemcitabine plus paclitaxel in patients with metastatic breast cancer and prior anthracycline treatment

✍ Binghe XU; Zhenzhou SHEN; Zefei JIANG; Zhongzhen GUAN; Xiaoqing ZHANG 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 608 KB

Paclitaxel combined with ifosfamide in a

Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance

✍ Yong Wha Moon; Joo Hyuk Sohn; Hye Jin Choi; Hyun Chang; Byeong-Woo Park; Seung I 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 175 KB

1866 THE EFFICIENCY OF SECOND-LINE CHEMO

1866 THE EFFICIENCY OF SECOND-LINE CHEMOTHERAPY WITH GEMCITABINE AND PACLITAXEL FOR ADVANCED UROTHELIAL CARCINOMA RESISTANT TO CISPLATIN-BASED CHEMOTHERAPY

✍ Nishihara, Chikako; Kuratsukuri, Katsuyuki; Iguchi, Taro; Tamada, Satoshi; Tanak 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 130 KB

An EORTC-IDBBC phase I study of gemcitab

An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes

✍ A Awada; L Biganzoli; T Cufer; L Beex; C Lohrisch; V Batter; A Hamilton; M Nooij 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 101 KB